IL27897A - Preparation of pyrazinoylguanidines and pyrazinamidoguanidines - Google Patents
Preparation of pyrazinoylguanidines and pyrazinamidoguanidinesInfo
- Publication number
- IL27897A IL27897A IL2789767A IL2789767A IL27897A IL 27897 A IL27897 A IL 27897A IL 2789767 A IL2789767 A IL 2789767A IL 2789767 A IL2789767 A IL 2789767A IL 27897 A IL27897 A IL 27897A
- Authority
- IL
- Israel
- Prior art keywords
- guanidine
- lower alkyl
- amino
- alkyl
- diamino
- Prior art date
Links
- 238000002360 preparation method Methods 0.000 title description 5
- WNBSDCKJFDZMHT-UHFFFAOYSA-N n-(diaminomethylidene)pyrazine-2-carboxamide Chemical class NC(N)=NC(=O)C1=CN=CC=N1 WNBSDCKJFDZMHT-UHFFFAOYSA-N 0.000 title description 2
- USVSPZQIBAJOIQ-UHFFFAOYSA-N n-(diaminomethylideneamino)pyrazine-2-carboxamide Chemical class NC(=N)NNC(=O)C1=CN=CC=N1 USVSPZQIBAJOIQ-UHFFFAOYSA-N 0.000 title description 2
- ZRALSGWEFCBTJO-UHFFFAOYSA-N Guanidine Chemical compound NC(N)=N ZRALSGWEFCBTJO-UHFFFAOYSA-N 0.000 claims description 59
- CHJJGSNFBQVOTG-UHFFFAOYSA-N N-methyl-guanidine Natural products CNC(N)=N CHJJGSNFBQVOTG-UHFFFAOYSA-N 0.000 claims description 32
- SWSQBOPZIKWTGO-UHFFFAOYSA-N dimethylaminoamidine Natural products CN(C)C(N)=N SWSQBOPZIKWTGO-UHFFFAOYSA-N 0.000 claims description 31
- 125000000217 alkyl group Chemical group 0.000 claims description 28
- 238000000034 method Methods 0.000 claims description 27
- -1 diaminopyrazinamido Chemical group 0.000 claims description 11
- 238000006243 chemical reaction Methods 0.000 claims description 9
- 239000001257 hydrogen Substances 0.000 claims description 7
- 229910052739 hydrogen Inorganic materials 0.000 claims description 7
- 125000004435 hydrogen atom Chemical class [H]* 0.000 claims description 7
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 6
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 claims description 6
- 239000000203 mixture Substances 0.000 claims description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 6
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 claims description 4
- 238000005660 chlorination reaction Methods 0.000 claims description 4
- 229910052801 chlorine Inorganic materials 0.000 claims description 4
- 239000000460 chlorine Substances 0.000 claims description 4
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 claims description 4
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 claims description 2
- 235000019253 formic acid Nutrition 0.000 claims description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims 2
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 claims 1
- RXMUPNVSYKGKMY-UHFFFAOYSA-N 3-amino-6-chloro-n-(diaminomethylidene)-5-(dimethylamino)pyrazine-2-carboxamide Chemical compound CN(C)C1=NC(N)=C(C(=O)N=C(N)N)N=C1Cl RXMUPNVSYKGKMY-UHFFFAOYSA-N 0.000 claims 1
- CEEBFRBDJOXNEF-UHFFFAOYSA-N 3-amino-n-(diaminomethylidene)-5-(dimethylamino)pyrazine-2-carboxamide Chemical compound CN(C)C1=CN=C(C(=O)N=C(N)N)C(N)=N1 CEEBFRBDJOXNEF-UHFFFAOYSA-N 0.000 claims 1
- 238000013019 agitation Methods 0.000 claims 1
- 125000005036 alkoxyphenyl group Chemical group 0.000 claims 1
- 239000002904 solvent Substances 0.000 claims 1
- 229960004198 guanidine Drugs 0.000 description 24
- 239000000047 product Substances 0.000 description 14
- 125000004432 carbon atom Chemical group C* 0.000 description 11
- 239000000376 reactant Substances 0.000 description 8
- HAMNKKUPIHEESI-UHFFFAOYSA-N aminoguanidine Chemical compound NNC(N)=N HAMNKKUPIHEESI-UHFFFAOYSA-N 0.000 description 7
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 7
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 5
- 235000017168 chlorine Nutrition 0.000 description 5
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 4
- 229910052799 carbon Inorganic materials 0.000 description 4
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 4
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 4
- 125000000740 n-pentyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 4
- 239000002244 precipitate Substances 0.000 description 4
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 4
- 238000003756 stirring Methods 0.000 description 4
- 125000001309 chloro group Chemical class Cl* 0.000 description 3
- 239000007858 starting material Substances 0.000 description 3
- KEWLVUBYGUZFKX-UHFFFAOYSA-N 2-ethylguanidine Chemical compound CCNC(N)=N KEWLVUBYGUZFKX-UHFFFAOYSA-N 0.000 description 2
- DOADNPZTVBOYFT-UHFFFAOYSA-N 3-amino-5-(benzylamino)-6-chloro-n-(diaminomethylidene)pyrazine-2-carboxamide Chemical compound N1=C(N)C(C(=O)NC(=N)N)=NC(Cl)=C1NCC1=CC=CC=C1 DOADNPZTVBOYFT-UHFFFAOYSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- KZBUYRJDOAKODT-UHFFFAOYSA-N Chlorine Chemical compound ClCl KZBUYRJDOAKODT-UHFFFAOYSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 125000003545 alkoxy group Chemical group 0.000 description 2
- XSDQTOBWRPYKKA-UHFFFAOYSA-N amiloride Chemical compound NC(=N)NC(=O)C1=NC(Cl)=C(N)N=C1N XSDQTOBWRPYKKA-UHFFFAOYSA-N 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 239000002934 diuretic Substances 0.000 description 2
- 239000012535 impurity Substances 0.000 description 2
- 239000000155 melt Substances 0.000 description 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 150000003254 radicals Chemical class 0.000 description 2
- 239000011541 reaction mixture Substances 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- YBBRCQOCSYXUOC-UHFFFAOYSA-N sulfuryl dichloride Chemical compound ClS(Cl)(=O)=O YBBRCQOCSYXUOC-UHFFFAOYSA-N 0.000 description 2
- LINDOXZENKYESA-UHFFFAOYSA-N 1,2-dimethylguanidine Chemical compound CNC(N)=NC LINDOXZENKYESA-UHFFFAOYSA-N 0.000 description 1
- LDXJRKWFNNFDSA-UHFFFAOYSA-N 2-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)-1-[4-[2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidin-5-yl]piperazin-1-yl]ethanone Chemical compound C1CN(CC2=NNN=C21)CC(=O)N3CCN(CC3)C4=CN=C(N=C4)NCC5=CC(=CC=C5)OC(F)(F)F LDXJRKWFNNFDSA-UHFFFAOYSA-N 0.000 description 1
- ABSNGNUGFQIDDO-UHFFFAOYSA-N 2-benzylguanidine Chemical compound NC(N)=NCC1=CC=CC=C1 ABSNGNUGFQIDDO-UHFFFAOYSA-N 0.000 description 1
- LSESKQAQXCAXMF-UHFFFAOYSA-N 3,5-diamino-n-(diaminomethylidene)pyrazine-2-carboxamide Chemical compound NC(=N)NC(=O)C1=NC=C(N)N=C1N LSESKQAQXCAXMF-UHFFFAOYSA-N 0.000 description 1
- IBLOAFCONPAYDW-UHFFFAOYSA-N 3-(methylamino)pyrazine-2-carboxylic acid Chemical compound CNC1=NC=CN=C1C(O)=O IBLOAFCONPAYDW-UHFFFAOYSA-N 0.000 description 1
- QCQCHGYLTSGIGX-GHXANHINSA-N 4-[[(3ar,5ar,5br,7ar,9s,11ar,11br,13as)-5a,5b,8,8,11a-pentamethyl-3a-[(5-methylpyridine-3-carbonyl)amino]-2-oxo-1-propan-2-yl-4,5,6,7,7a,9,10,11,11b,12,13,13a-dodecahydro-3h-cyclopenta[a]chrysen-9-yl]oxy]-2,2-dimethyl-4-oxobutanoic acid Chemical compound N([C@@]12CC[C@@]3(C)[C@]4(C)CC[C@H]5C(C)(C)[C@@H](OC(=O)CC(C)(C)C(O)=O)CC[C@]5(C)[C@H]4CC[C@@H]3C1=C(C(C2)=O)C(C)C)C(=O)C1=CN=CC(C)=C1 QCQCHGYLTSGIGX-GHXANHINSA-N 0.000 description 1
- LSNNMFCWUKXFEE-UHFFFAOYSA-M Bisulfite Chemical compound OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 description 1
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 1
- GAWIXWVDTYZWAW-UHFFFAOYSA-N C[CH]O Chemical group C[CH]O GAWIXWVDTYZWAW-UHFFFAOYSA-N 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 1
- DWAQJAXMDSEUJJ-UHFFFAOYSA-M Sodium bisulfite Chemical compound [Na+].OS([O-])=O DWAQJAXMDSEUJJ-UHFFFAOYSA-M 0.000 description 1
- JAWMENYCRQKKJY-UHFFFAOYSA-N [3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-ylmethyl)-1-oxa-2,8-diazaspiro[4.5]dec-2-en-8-yl]-[2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidin-5-yl]methanone Chemical compound N1N=NC=2CN(CCC=21)CC1=NOC2(C1)CCN(CC2)C(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F JAWMENYCRQKKJY-UHFFFAOYSA-N 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 125000005907 alkyl ester group Chemical group 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 239000003125 aqueous solvent Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 1
- 229910052794 bromium Inorganic materials 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 239000003638 chemical reducing agent Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 239000011737 fluorine Substances 0.000 description 1
- 239000012458 free base Substances 0.000 description 1
- 229910052736 halogen Inorganic materials 0.000 description 1
- 150000002367 halogens Chemical group 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- LMGVITOFKPGSPZ-UHFFFAOYSA-N methyl 3,5-diaminopyrazine-2-carboxylate Chemical compound COC(=O)C1=NC=C(N)N=C1N LMGVITOFKPGSPZ-UHFFFAOYSA-N 0.000 description 1
- 230000001452 natriuretic effect Effects 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 239000012299 nitrogen atmosphere Substances 0.000 description 1
- 230000001473 noxious effect Effects 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- NIPZZXUFJPQHNH-UHFFFAOYSA-N pyrazine-2-carboxylic acid Chemical compound OC(=O)C1=CN=CC=N1 NIPZZXUFJPQHNH-UHFFFAOYSA-N 0.000 description 1
- 125000000719 pyrrolidinyl group Chemical group 0.000 description 1
- 239000012429 reaction media Substances 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 235000010267 sodium hydrogen sulphite Nutrition 0.000 description 1
- 125000001424 substituent group Chemical group 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
- C07D241/10—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D241/14—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D241/24—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D241/26—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with nitrogen atoms directly attached to ring carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Description
'nitui ffiD TJinrn ·π PATENT ATTORNEYS · □ ' Q ] Q D ' □ 1 DR. REINHOLD COHN I Π 3 TJini' · Ί ' Π DR. MICHAEL COHN in. 1 N a · D m ISRAEL SHACHTER B.Sc. .0.1 T D 3 LU IN T CU ' PATENTS AND DESIGNS ORDINANCE SPECIFICATION Preparation of Fyrazlnoylguanidines and Pyrazinamidoguanidines MERC & CO., Inc. a corporation of New Jerse ,U.S.A. , fiahway. New Jersey U.S.A. do hereby declare the nature of this invention and in what manner the same is to be performed, to particularly described and ascertained in and by th following statement : - This invention is concerned with a novel process for the preparation of ( 3, 5-diamino-6-chloropyrazinoyl)guani- other abnormalities resulting from the retention of excess quantities of sodium and/or fluid by the animal organism.
The novel process of this invention involves the chlorination of a ( 3* 5-diaminopyrazinoyl)guanidine or a .(3* 5- diaminopyrazinamldo)guanidine compound. This novel process presents a simple and highly economical method of producing an important group of diuretic or natriuretic products.
The novel process of this invention advantageousl is carried out by preparing a solution of the ( 3, 5-diaminopy- razinoyl)guanidine or the ( 3, 5-diaminopyrazinamido)guanidine product in an aqueous or organic solvent such as a mixture of water and acetic acid or water and dloxane, acetonitrile, formic acid and the like. Chlorine gas then is .passed through the solution thus prepared for sufficient time to ensure chlor- inatlon of the starting material. Chlorination is- acilita- ted by vigorous stirring of the reaction mixture during the addition of chlorine. In some instances and under certain reaction conditions chlorine is added to one or more of the amino groups of the starting material and, If desired, these chlorines can be removed by treating the product of chlorina- tion with sodium bisulfite or some related reducing agent which will remove all of the chlorines except that which is - lb - It Is known from Dutch Patent Application No. 6,409,717 (C.A. Vol.64, p. 8208 e) to introduce chlorine atoms into the 5- and/or 6-positions of a 3-amino-pyraisinoic acid derivative' , by means of sulphuryl chloride. This known process, however, has the disadvantage of employing the highly noxious and corrosive sulphuryl chloride reagent, of the formation of many colored impurities necesoitating lengthy., and difficult purification steps and, consequently, of rele ively low yields.
In contrast to the above mentioned known process, the novel process according to the present invention is less!¾onsum-ing and affords higher yields. It can be carried out with most ordinary equipment without hazards to operator or reaction vessels; impurities are not formed and as the end product precipitates from the reaction mixture, it can be separated merely by filtration and no additional purification steps are required.
While the novel method of this invention can be em-ployed to produce substantially any ( 3, 5-diamino-6-chloropy-razinoyl)guanidine or ( 3, 5-diamino-6-chloropyrazinamido)guani~ dine product, the reaction is particularly suited to the prepa-ration of products having the following structural formula wherein R1 and R2 can be the same or dissimilar groups selec-ted from hydrogen, lower alkyl advantageously having from 1 to 5 carbon atoms as methyl, ethyl, propyl, isopropyl, butyl, amyl, or any of the branched or 5 carbon alkyl groups, or a phenyl-lower alkyl advantageously having 1 or 2 carbons in the alkyl moiety; R3 represents hydrogen, a lower alkyl having from 1 to 5 carbon atoms such as methyl, ethyl, propyl, iso-propyl, butyl, amyl or any of the branched 4 or 5 carbon lower alkyl groups, or substituted lower alkyl groups having from 1 to 5 carbon atoms and particularly those containing hydroxy or a heterocyclic substituent such as the pyrridyl substituent or a phenyl substituent, the phenyl-lower alkyl advantageously having an alkyl moiety of 1 to 2 carbon atoms and the phenyl moiety being either unsubstituted or substituted with one or more halogens (preferably chlorine, ( bromine, fluorine), lower alkyl (having 1 to 2 carbon atoms) and/or lower alkoxy (having 1 to 2 carbon atoms) groups; R4 advantageously is hydrogen, lower alkyl having 1 to 5 carbon atoms such as methyl, ethyl, propyl, isopropyl, butyl, amyl or any of the branched 4 or carbon alkyl groups, phenyl-lower alkyl wherein the alkyl moiety advantageously has from 1 to 2 carbon atoms and the from 1 to 2 carbon atoms) and/or lower alkoxy (having 1 to 2 carbon atoms) groups; when R3 and R4 are each lower alkyl they can be linked together to form a cyclic structure with the nitrogen atjom to which they are attached thereby forming a group ,( wherein x preferably is one of the numerals from 4 through 7 thus yielding, for example, the pyrrolidinyl group; R5 ad-vantageously is hydrogen or lower alkyl having from 1 to 5 carbon atoms such as methyl, ethyl, propyl, isopropyl, butyl, amyl or any of the branched 4 or 5 carbon alkyl groups; and when Rs and R4 each are lower alkyl they can be linked together o form the structure wherein _ preferabl " is one of the numerals 2 or 3; and n is either 0 or 1.
The novel process of this invention can be illustra-ted by the following reaction scheme wherein the variable radi-cals have the meaning assigned to each of them above.
The starting materials (ll) are, for the most part, known com-pounds, or can be prepared by the reaction of a lower alkyl ester of S-amino-S-NR^-R^-pyrazinoate with the desired guani-dine or aminoguanidine having the structure · R3 1 wherein the variable radicals n, R3, R4 and Rs have the mean- 2 ing assigned above. The guanidine or aminoguanidine reactants 9 While the following examples illustrate the novel .0 process of this invention, it is to be understood that the 1 examples are not to be considered as limiting the invention 2 to the particular products prepared nor to the particular re- 3 action conditions described, but are to be understood as illus- trating solely a particular embodiment of the invention fall- 5 ing within the scope of the reaction conditions and products 6 described hereinabove. 7 EXAMPLE 1 8 ( 3J 5-Diamino-6-chloropyrazlnoyl)guanidine 9 Step A: Preparation of ( .5-diaminopyrazinoyl)guanidine 0 Absolute alcohol (2 liters) is flushed with dry ni- 1 trogen and to it is added 0.6 mole of clean sodium. Guanidine 2 hydrochloride (θ.β mole) then is added with stirring. After 3 precipitation of the sodium chloride is complete, the mixture 4 is filtered under a nitrogen atmosphere and anhydrous condi- 5 tions. Methyl 3,5-diaminopyrazinoate (θ.β mole) is added to 6 the filtrate with stirring and the mixture is heated to 60° C. 7 and then allowed to cool to room temperature spontaneously. 8 The precipitate is collected, washed, with ethanol and dried 9 to give (3, -diaminopyrazinoyl)guanidine, ir p. 286-288° C. 0 (dec. ) . 1 acid and 0.6 mole of ( 3, 5-diaminopyrazinoyl)guanidine is heat- 2 ed to 40° C. While vigorously stirring the reaction medium, 3 about 140 g. of chlorine gas is passed through the solution 4 over a period of about 30 minutes. The precipitate that forms on cool|ng is collected and stirred with a solution of 6 150 g. of sq jium bisulfite in 1 liter of water. After about 7 one-half houf, the precipitate is collected, washed with water 8 and dried to give (3, 5-diamino-6-chloropyrazinoyl)guanidine, 9 m.p. 240.5-241.5° C (dec).
EXAMPLE 2 11 ( 3-Amino-5-dimethylamino-6»chloropyrazinoyl)guanidine 12 By replacing the pyrazinoate employed in Example 1, 13 Step A, by an equimolecular' quantity of methyl 3-amino-5-di- 14 methylaminopyrazinoate and ihen following substantially the same conditions and employing the other reactants of Example l6. 1, Step A, there is obtained ( 3-ajnino-5-dimethylaminopyrazin- 17 oyl)guanidine, m.p. 224-225° C. (dec). Upon chlorinating 18 this product by the procedure described in Example 1, Step B, 19 there is obtained ( 3-amino-5-dimethylamino-6-pyrazinoyl)guani- 0 dine, m.p. 216-217° C. (dec). 1 EXAMPLE 3 2 ' ( 3-Amino-5-benzylamino-6-chloropyrazinoyl)guanidine 3 By replacing the ester used in Example 1, Step A, 4 by an equimolecular quantity of methyl 3-amino-5-benzylam~ino- 5 pyrazinoylguanidine and then following substantially the same 6 procedure and using the other reactants called for in Example 7 l, Step A, there is obtained ( 3-amino-5-benzylaminopyrazinoyl)- 8 guanidine, m.p. 231-233° C. (dec). This product can be chlor- 9 inated by substantially the same procedure described. in 1 Example 1, Step B, to give ( 3-amino-5-benzylamino-6-chloro- 2 pyrazinoyl)guanidine. 3 EXAMPLE ( 3> 5"Piamino-6-»chloropyrazinamldo)guanidine This product is prepared following substantially the same procedures described in Example 1, Steps A and -B, f with the exception that in place of ^guanidine employed in J3 Step A an equimolecular quantity of aminoguanidine is substi- tuted therefor. The ( 3* 5-diamino-6-chloropyrazinamido)guani- 10 dine thus obtained, in the form of its hydrochloride salt, 11 melts at 281-282° C. 12 EXAMPLE 5 13 ( 3-Amino-5-dimethylamino-6-pyrazinamido)guanidine 1 This product is prepared following substantially . the same procedures described in Example 2 except in place 1β of guanidine employed in Example 2 an equimolecular quantity 17 of aminoguanidine is substituted therefor. The ( 3~amino-5~ 18 dimethylamino-6-chloropyrazinamido)guanidine product thus ob- 19 tained melts at 221° C.
EXAMPLE 6 21 ( 3-Amino-5-benzylamino-6-chloropyrazlnamldo)- 22 j guanidine 23 This product is prepared following substantially the same procedure described in Example 3 with the exception that aminoguanidine is substituted for the guanidine reactant 26 and ( 3-amino-5-benzylamino-6-chloropyrazinamido)guanidine is 27 obtained. 28 .By replacing the aminoguanidine reactant employed 29 in Example , 5, and 6 by an equimolecular quantity of ' ' l-amino-3-methylguanidine, - - - 2-h drox eth l uanidine l-amino-2, 3-ethyleneguanidine, and l-amino-3, 3-dimethylguanidine, and then following substantially the same procedures and us- ing the other reactants, reagents and reaction conditions described in Examples 4, 5 and 6, there are ^obtained (a) by employing Example 4 conditions: 3j 5?;piamino-6-chloropyrazinamido -3-methylguanidine, : l-( 3, 5-diamino-6-chloropyrazinamido) -3-( 2-hydroxyethyl)- < guanidine · 1- ( 315-diamino-6-chloropyrazinamido) -3-phenethylguanidine, l-( 3* 5-diamino-6-chloropyrazinamido) -3~benzylguanidine, l-( 3i 5-diamino-6-chloropyrazinamido) -2, 3-ethyleneguani- · dine and l-( 3^ 5-diamino-6-chloropyrazinamido) -3* 3-dimethylguani- · dine; (b) by employing Example 5 conditions: l-( 3-amino-5-dimethylamino-6-chloropyrazinamid6) -3-methyl- · guanidine, l- ( 3-amino-5-dimethylamino-6-chloropyrazinamido) -3- ( 2- · · hydroxyethyl)guanidine, l-( 3-amino-5-dimethylamino-6-chloropyrazinamido) -3-phen- · ethylguanidine, l-( 3-amino-5-dimethylamino-6-chloropyrazinamido) -3-benzyl- · guanidine, l-( 3-amino-5-dimethylamino-6-chloropyrazinamido) -2, 3- « ethyleneguanidinei'.and 1- ( 3-amino-5-dimethylamino-6-chloropyrazinamido) -3, 3- · dimethylguanidine; (c) by employing Example 6 conditions: l-( 3-amino-5-benzylamino-6-chloropyrazinamido) -3-methyl-■ · guanidine, l-( 3-amino-5-benzylamino-6-chloropyrazinamido) -3- (2-hy- · droxyethyl)guanidine, l-( 3-amino-5-benzylamino-6-chloropyrazinamido) -3-phen- · ethylguanidine, l-( 3-amino-5-benzylamino-6-chloropyrazinamido) -3-benzyl- 1 l-(3-amino-5-benzylamino-6-chloropyrazinamldo)-3*3-di- 2 · methylguanidine . 3 The! following table identifies other products that 4 can be prepared by the process of this invention'. The method II is replaced by the guanidine or aminoguanidine reactant (ill) 12 identified in the table. In all other respects the reactants 13 and reaction conditions are as described in Example 1, Steps A 1 and B.
CH3 H H 252-25 CH3 CH3 H 295 C2Hs C2Hs ' H 265 (HCI -CH2-@ H H 215-216 -CH2-£¾ Ή ' H 220-223 ■ tf : .
-CH2- -F H H 216-219.5 -CH2-@-CH3 H H 210-212 -CH2CH2-@ H H ■ 219-22I.5 (2 HCl) ' CH3 CH3. H 279-28Ο m.p. is given for the free base unless otherwise noted
Claims (1)
1. HAVING NOW particularly described and ascertalnd the n$$ure o our said Invention and in what manner the same is to be performed, we ; declare that what we claim Is: WHAT IS CLAIMED IS: 1 1. A process comprising the reaction of a product 2 I selected from a (3> 5-dlaminopyrazinoyl)guanldine and a (3,5- 3 diaminopyrazinamido)guanidine with chlorine to give the (3,5- '; 4 diamino-6-chlo:tjfopyrazinoyl)guanidlne and (3i -diamino-6-chlo- 5 ropyrazinamido)guanidine products. 1 2. A process as claimed in claim 1 wherein the 2 product I is dissolved in a solvent and agitation of the re- 3 action mixture is continued throughout the chlorination pro- 4 cedure. 1 · 3. A process as claimed in claim 2 wherein the sol- 2 vent is selected from a mixture of water and acetic acid, a 3 mixture of water and dioxane, acetonitrile and formic acid. 1 . A process as claimed in claim 1 wherein product 2 I has the structural formula 4 wherein R1 and R2 are either similar or dissimilar groups and 5 are separately selected from hydrogen, lower alkyl and phenyl- 6 lower alkyl; R3 is selected from the group consisting of hy- 7 drogen, lower alkyl, hydroxy-lower alkyl, phenyl-lower alkyl, 8 halo-phenyl-lower alkyl, lower-(alkylphenyl)alkyl, and lower- 9 (alkoxyphenyl)alkylj R4 is selected from the group, consistin 10 of hydrogen, lower alkyl, phenyl-lower alkyl, halophenyl-low- 11 er alkyl, lower-(alkylphenyl)alkyl and lower-(alkoxyphenyl) - 12 alkylj R5 is selected from the group consisting of hydrogen, 13 and lower alkyl; and when R4 and R5 each are lower alkyl they 14 can he linked to ether to form the structure -C-→I 3wherein 5· process as claimed in claim 3 wherein (3*5-diaminopyrazijfioyl)guanidine is chlorinated to give (3*5~di-aminp-6-chloropyrazinoyl)guanidine. 6. A process as claimed in claim 3 wherein (3-amino-5-dimethylaminopyrazinoyl)guanidine is chlorinated to give (3-amino-5-dimethylamino-6-chloropyrazinoyl)guanidine . 7. A process as claimed in claim 3 wherein (3*5-diaminopyrazinamido)guanidine is chlorinated to give (3*5-/ diamino-6-chloropyrazlnamido)guanidine. Dated this 50th day of April,1967
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US57492266A | 1966-08-25 | 1966-08-25 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL27897A true IL27897A (en) | 1972-02-29 |
Family
ID=24298194
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL2789767A IL27897A (en) | 1966-08-25 | 1967-05-02 | Preparation of pyrazinoylguanidines and pyrazinamidoguanidines |
Country Status (8)
| Country | Link |
|---|---|
| BE (1) | BE699438A (en) |
| CH (1) | CH487169A (en) |
| DE (1) | DE1695421A1 (en) |
| ES (1) | ES341324A1 (en) |
| GB (1) | GB1145934A (en) |
| IL (1) | IL27897A (en) |
| NL (1) | NL6707570A (en) |
| SE (1) | SE333146B (en) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6858615B2 (en) | 2002-02-19 | 2005-02-22 | Parion Sciences, Inc. | Phenyl guanidine sodium channel blockers |
| EP2231280B1 (en) | 2007-12-10 | 2016-08-10 | Novartis AG | Amiloride-like Pyrazine-carboxamides as ENaC blockers |
| AR086745A1 (en) | 2011-06-27 | 2014-01-22 | Parion Sciences Inc | 3,5-DIAMINO-6-CHLORINE-N- (N- (4- (4- (2- (HEXIL (2,3,4,5,6-PENTAHYDROXIHEXIL)) AMINO) ETOXI) PHENYL) BUTIL) CARBAMIMIDOIL) PIRAZINA -2-CARBOXAMIDE |
| CN105073717B (en) | 2012-12-17 | 2018-05-22 | 帕里昂科学公司 | Chloro-pyrazinecarboxamide derivatives useful in the treatment of diseases caused by insufficient mucosal hydration |
| CN108658876A (en) | 2012-12-17 | 2018-10-16 | 帕里昂科学公司 | The chloro- N- of 3,5- diamino -6- (N- (4- phenyl butyls) carbonamidine base) pyrazine -2- benzamide compounds |
| US9102633B2 (en) | 2013-12-13 | 2015-08-11 | Parion Sciences, Inc. | Arylalkyl- and aryloxyalkyl-substituted epithelial sodium channel blocking compounds |
-
1967
- 1967-05-02 IL IL2789767A patent/IL27897A/en unknown
- 1967-05-31 NL NL6707570A patent/NL6707570A/xx unknown
- 1967-06-02 ES ES341324A patent/ES341324A1/en not_active Expired
- 1967-06-02 BE BE699438D patent/BE699438A/xx unknown
- 1967-06-02 DE DE19671695421 patent/DE1695421A1/en active Pending
- 1967-06-07 CH CH804067A patent/CH487169A/en not_active IP Right Cessation
- 1967-06-07 GB GB2621767A patent/GB1145934A/en not_active Expired
- 1967-06-09 SE SE813267A patent/SE333146B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ES341324A1 (en) | 1968-10-01 |
| SE333146B (en) | 1971-03-08 |
| NL6707570A (en) | 1968-02-26 |
| BE699438A (en) | 1967-12-04 |
| GB1145934A (en) | 1969-03-19 |
| CH487169A (en) | 1970-03-15 |
| DE1695421A1 (en) | 1971-04-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US2933502A (en) | Benzimidazolone derivatives | |
| CH653989A5 (en) | CYCLOBUTENDION CONNECTIONS. | |
| CH646156A5 (en) | SULPHUR CONTAINING benzimidazole derivatives AND PROCESS FOR PRODUCING. | |
| IL27897A (en) | Preparation of pyrazinoylguanidines and pyrazinamidoguanidines | |
| EP0052333B1 (en) | 4-fluoro-5-oxypyrazole derivate and preparation thereof | |
| US2980665A (en) | Pyrimidines | |
| US3966728A (en) | Benzoguanamine derivatives | |
| US3244723A (en) | Certain 4-aminothiazole compounds and their preparation | |
| US3911012A (en) | Method of preparing 4-chloro-derivatives of phenylformamidine and salts thereof | |
| US3417080A (en) | Sulfamylanthranilic acid amides and process for preparing them | |
| JPS6236366A (en) | Production of 2-cyanoamino-pyrimidine derivative | |
| JPH0217163A (en) | Production of diaminomaleonitrile and diaminoacrylonitrile derivative | |
| IE46671B1 (en) | Preparation of isobutyramide derivatives | |
| US3128273A (en) | 4-amino-pteridine-7-carboxamides and method of preparation | |
| AT394193B (en) | Process for the preparation of novel 5-fluoronicotinic acids or derivatives and salts thereof | |
| JPH04120055A (en) | Acyl arysulfenyl selenide derivative and production thereof | |
| US3106555A (en) | Novel amino chlorosulfenyl-s-triazines, their hydrochlorides and process for their production | |
| JPS6354707B2 (en) | ||
| DE2306001C3 (en) | Pyrimidine derivatives, processes for their preparation and poultry feed compositions containing them | |
| AT234685B (en) | Process for the preparation of new 3-phenyl-sydnonimines | |
| AT278778B (en) | PROCESS FOR THE PREPARATION OF NEW BENZHETEROCYCLIC COMPOUNDS AND THEIR SALTS | |
| CH369457A (en) | Process for the preparation of pyrimidines | |
| AT258916B (en) | Process for the preparation of new alkyl 3-amino-5-chloro-6-X-pyrazinoates | |
| DE2306112A1 (en) | THIOURAL DERIVATIVES OF VITAMIN ASAEURS | |
| JPS60152450A (en) | Production of alpha-aminoketone |